Currently out of the existing stock ratings of Jeffrey Garro, 56 are a BUY (67.47%), 25 are a HOLD (30.12%), 2 are a SELL (2.41%).

Jeffrey Garro

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Garro, currently employed at STEPHENS, carries an average stock price target met ratio of 41.56% that have a potential upside of 13.16% achieved within 91 days.

Jeffrey Garro’s has documented 165 price targets and ratings displayed on 15 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on MDRX, Allscripts Healthcare Solutions at 14-Nov-2023.

Wall Street Analyst Jeffrey Garro

Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 7/26/2023. The price target of $28 was fulfilled within 1 day with a profit of $0.92 (3.18%) receiving and performance score of 31.81.

Average potential price target upside

of $10.82 (14.51%) on CERN (CERNER CORP).
of $6.82 (42.78%) on NXGN (NEXTGEN HEALTHCARE).
of $1.42 (4.41%) on APR (APRIA).

APR Apria BHG Bright Health Group INNV InnovAge Holding Corp SLQT Selectquote ALHC Alignment Healthcare LLC IQV IQVIA Holdings MDRX Allscripts Healthcare Solutions NXGN Nextgen Healthcare ACCD Accolade CERN Cerner Corp CERT Certara CPSI Computer Programs and Systems OPRX OPTIMIZERx Corp PHR Phreesia TDOC Teladoc

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Whit Mayo (UBS)